The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Suvezen 20 mg/10 mg film-coated tablets

20/10 milligram(s) Film-coated tablet

Sanofi-Aventis Ireland Limited T/A SANOFIPA0540/193/002

Main Information

Trade NameSuvezen 20 mg/10 mg film-coated tablets
Active SubstancesRosuvastatin
Ezetimibe
Strength20/10 milligram(s)
Dosage FormFilm-coated tablet
Licence HolderSanofi-Aventis Ireland Limited T/A SANOFI
Licence NumberPA0540/193/002

Group Information

ATC CodeC10BA02 simvastatin and ezetimibe

Status

Authorised/WithdrawnAuthorised
Licence Issued14/06/2019
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable List CodeIC0111-061-009
Interchangeable List DocumentPDF of Interchangeable List
« Back